The Deadly Drug Everyone Is Taking
AsapSCIENCE — The Deadly Drug Everyone Is Taking (BPC-157, fact-checked claim by claim)
Channel: AsapSCIENCE · Our label: Mainstream science media — critic · Published: June 30, 2026 · Views at last check: ~242,000 (November 7, 2026) · Source: youtube.com/watch?v=Cxe5I4MfJ9I
Featured — and checked. This is the video that took the critics’ case against gray-market peptides mainstream: a top-50 global science channel with about 10.8 million subscribers, no clinic and no storefront, aiming its drug-scare franchise format at BPC-157. We pulled its sources and graded every load-bearing claim. The scorecard is below; the full working is in our claim-by-claim fact-check.
What this video covers
The video opens with a claim that U.S. imports of unregulated injectable chemicals from China doubled in 2025, then backs up to first principles — amino acids, protein folding, and why “peptides” names a category of trillions of possible molecules, not one thing. It narrows to BPC-157, the healing peptide it calls infamous: popularized by influencers (Andrew Huberman’s use is named), credited with faster recovery from injury, and — in the video’s central charge — resting on a literature produced overwhelmingly by one Croatian lab, in animals, with no proper human trials behind it.
From there it argues the product itself can’t be trusted (a contamination anecdote involving lead), raises a cancer case built on trefoil peptides and blood-vessel growth, and names the engine underneath the boom: “anecdata” — social-media anecdotes amplified by influencers whose business model, the video argues, is distrust of doctors. It supports that argument with two large studies (a 16,000-person survey of false health beliefs, and an analysis of about a thousand social-media accounts promoting medical screening tests) and a segment linking body dysmorphia to young people’s gray-market use. It closes with advice: talk to a licensed doctor in person, and wait until these compounds are properly tested in humans.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-09). The video’s claims are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- Peptides are short chains of amino acids; with 20 amino acids, even a 10-link chain has over 10 trillion possible combinations — so any honest conversation has to name a specific compound.
- Most of the 200-plus papers on BPC-157 come from one lab — and when you ask an AI chatbot about BPC-157, “all roads lead back to this one lab.”
- The research is in animals; there are no proper, effective, safe human trials of BPC-157 in the medical community right now.
- “Anecdata” — random comments and personal stories — is not evidence; there is no way to know whether an injection caused a reported benefit or a reported harm.
- A 16,000-person study found 25–32% of people believing specific false health claims, from vaccine conspiracies to fluoride fears.
- Influencers make money when you take your health into your own hands: clicks, supplements, scans and apps are the business model.
- The closing advice: before injecting anything, talk to a licensed doctor in person — and wait for human testing.
We checked this video
Our verdicts, in plain language. Supported = the record backs it. Mostly right = true with a correction attached. Overstated = a real thing stretched past its evidence. Unsupported = no source we could find backs it. Wrong as stated = the record says otherwise.
| The video’s claim | Our verdict | Why, in one line |
|---|---|---|
| Most BPC-157 research comes from one lab | Supported | A 2025 review in Pharmaceuticals (Józwiak et al.) counted 190+ papers; over 80% list Predrag Sikirić or Sven Seiwerth as first or senior author. |
| BPC-157 has not been properly tested in humans | Supported | A 2025 systematic review (Vasireddi et al.) found 35 of 36 included studies were preclinical; the entire published human record is about 30 people in three uncontrolled reports. |
| Sikirić discovered it in 1993 | Mostly right | The landmark paper is 1993 — but the lab’s work, and the patent filing, date to 1989. |
| “He currently holds the patent” | Wrong as stated | The molecule patent expired around 2011. STAT News and Undark (February 2026) reported the discoverer’s live, undisclosed stakes: part-ownership of the company that sponsored the only registered human trial, and a formulation patent at a company he leads. The full story |
| A buyer found lead in BPC-157 bought from a trusted source | Unsupported | No publication matching that story could be found. The wider record is real: peer-reviewed lab work found lead and arsenic above injectable limits in other falsified peptides — BPC-157 was not among the products tested — and a large independent dataset finds roughly one in three gray-market samples fail basic quality checks. |
| Trefoil peptides drive cancer spread, and BPC-157 is one of them | Overstated | The metastasis evidence concerns trefoil factor peptides (chiefly TFF3). BPC-157 is not a trefoil peptide — it has no trefoil domain and belongs to a different family. The graded version |
| BPC-157 increases free radicals | Unsupported | The published literature claims the opposite — free-radical scavenging. That claim is also unproven in humans, but the video’s arrow points the wrong way. |
| It grows blood vessels, so it could in theory lead to cancer | Mostly right | The mechanism is real and independently replicated (VEGFR2 activation, Hsieh et al. 2017), and independent reviewers raise the same open question. There are no human cancer data either way, no attributed cases, and no carcinogenicity studies. |
| U.S. imports of unregulated injectable chemicals from China doubled in 2025 | Overstated | Customs figures reported by The New York Times show a broad hormone-and-peptide category doubling — $164M to $328M, first three quarters of 2024 vs. 2025 — a category that includes bulk ingredients for legal GLP-1 compounding. The sharper gray-market measure is crypto payments to vendor wallets: $32M in Q1 2026 (Chainalysis). The numbers page |
| A 16,000-person study found 25–32% believing false health claims | Supported | The 2026 Edelman Trust Barometer health report (16,009 respondents, 16 countries) matches the video’s six figures exactly. The “first time ever” gloss is the video’s own addition. |
| About 1,000 social accounts pushing a screening test had financial incentives | Mostly right | JAMA Network Open (2025): 982 posts across five tests, 194 million followers; 68% of account holders had financial interests in what they promoted. |
| Eating disorders rose from 1990–2021, worst at ages 20–24 — and dysmorphia is driving peptide use | Overstated | The trend figures check out (Global Burden of Disease analysis, 2025). But that study does not measure muscle dysmorphia, and no study the video cites ties the trend to peptide use — the bridge is speculation. |
| Andrew Huberman has injected himself with BPC-157 | Supported | He has said so repeatedly, first person. What the video leaves out: his supply came by prescription through a compounding pharmacy, and he pairs the story with his own caveat that there is no clinical data — “it’s all animals.” |
| Influencers are making millions pushing this | Overstated | The ecosystem money is documented — AG1 built roughly $600M in 2024 revenue on the podcast model (Forbes), and gray-market vendors took $32M in crypto in one quarter (Chainalysis) — but no verified figure exists for peptide influencers as a class. |
| The title: “The deadly drug everyone is taking” | Unsupported | No death has been attributed to BPC-157 in any source we could find, and there is no human cancer evidence either way. The documented harm record is real but different: injuries tied to mislabeled and unsterile products. Calibrated in the fact-check |
The argument, in context
This video did not appear in a vacuum. Doctor Mike’s “Exposing The Truth About Peptides” made the physician-creator version of the case; specialists have answered back (Dr. Alex Tatem’s rebuttal series is in his hub; Dr. Jones DC reacted in his). We present the argument as an argument — every side transcribed, labeled, and linked.
Read next
- AsapSCIENCE Took On BPC-157. We Checked Every Claim. — the full fact-check
- The One-Lab Problem — the concept page this video inspired
- Cancer and Peptides: What Is Actually Known
- BPC-157 — compound page
- All videos from this channel
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.